Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-38,395
Closed -$1.12M 1325
2017
Q3
$1.12M Buy
38,395
+18,800
+96% +$483K 0.02% 847
2017
Q2
$508K Sell
19,595
-17,453
-47% -$418K 0.01% 940
2017
Q1
$911K Buy
+37,048
New +$907K 0.02% 800
2016
Q4
Sell
-29,205
Closed -$613K 1136
2016
Q3
$613K Buy
29,205
+197
+0.7% +$4.21K 0.02% 761
2016
Q2
$612K Buy
29,008
+7,371
+34% +$137K 0.03% 565
2016
Q1
$409K Buy
21,637
+7,093
+49% +$135K 0.03% 610
2015
Q4
$308K Sell
14,544
-4,733
-25% -$96.5K 0.02% 608
2015
Q3
$325K Buy
+19,277
New +$379K 0.05% 538

Other funds holding NEOG

AHL Partners's NEOG Position: Q4 2017 in Review

AHL Partners sold out of Neogen (NEOG) in Q4 2017, closing a stake of 38,395 shares — an estimated $1.12M sold.

AHL Partners first reported a position in NEOG in Q3 2015 and held it in 8 quarters. The position peaked at $1.12M in Q3 2017. 246 funds tracked by Wall St. Rank hold NEOG as of Q4 2017.

  • AHL Partners reported no remaining Neogen position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 38,395 Neogen shares in Q4 2017, an estimated $1.12M.
  • AHL Partners first reported a position in Neogen in Q3 2015 and held it in 8 quarters.
  • AHL Partners's Neogen position peaked at $1.12M in Q3 2017.
  • 246 funds tracked by Wall St. Rank held Neogen as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.